Skip to content
ClinCalc Pro
Menu
Topical Local Anaesthetic (Neuropathic Pain)

Lidocaine 5% Medicated Plaster

Brand names: Versatis

The lidocaine medicated plaster is a topical local anaesthetic patch licensed for localised neuropathic pain such as post-herpetic neuralgia and used for localised pain relief.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Lidocaine blocks voltage-gated sodium channels in local sensory nerve fibres, reducing ectopic nerve firing and dampening pain signalling in the area of application.

Prescribing in practice

  • Apply only to intact, non-irritated, non-broken skin, as application to damaged skin increases systemic absorption and the risk of toxicity.
  • Plasters are applied for a defined wear period followed by a plaster-free interval as stated in the SPC, and should be cut to size rather than overlapped where appropriate.
  • Systemic adverse effects are uncommon with correct use, but caution is advised in severe hepatic impairment and with other local anaesthetic exposure.

Monitoring

Monitor the application site for local skin reactions and review analgesic benefit to justify continued use.

Counselling the patient

  • Apply the plaster to healthy, unbroken skin over the painful area and follow the on/off timing you are given.
  • Remove the plaster if it causes skin irritation, and wash your hands after handling it.
  • Keep used and unused plasters away from children and pets.

Evidence & guidelines

The lidocaine medicated plaster is an established option for localised neuropathic pain such as post-herpetic neuralgia.

Reference: NICE TA159 (Lidocaine Plaster for PHN); MHRA SPC Versatis; EFLA94 trial; British Pain Society Guidelines; NICE NG59; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.